Thrombin generation in pediatric patients with Crohn's disease

Related Experiment Video

Updated: Jun 4, 2026

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well
08:01

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

Heike Bernhard1, Andrea Deutschmann, Bettina Leschnik

  • 1Department of Pediatrics, Medical University of Graz, Austria.

Inflammatory Bowel Diseases
|February 3, 2011
PubMed

Insights

Children with active Crohn's disease (CD) show increased thrombin generation, a hypercoagulable state linked to inflammation, not a pre-existing condition. This finding highlights inflammation's role in CD-related clotting risks.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Thrombosis Research

Background:

  • Inflammatory bowel disease (IBD), including Crohn's disease (CD), is associated with increased thromboembolic risk.
  • The exact pathogenesis of IBD is unclear, but heightened thrombin activity may play a role.
  • Calibrated automated thrombography (CAT) offers a comprehensive assessment of hemostasis.

Purpose of the Study:

  • To evaluate thrombin generation potential in children with CD using CAT.
  • To compare thrombin generation in active versus inactive CD.
  • To investigate correlations between hypercoagulability and disease activity in pediatric CD.

Main Methods:

  • Plasma samples from 22 children with CD and 61 healthy controls were analyzed.
  • Thrombin generation was measured using calibrated automated thrombography (CAT).
  • Disease activity was assessed via the Pediatric Crohn's Disease Activity Index (PCDAI), alongside other coagulation markers.

Main Results:

  • Children with active CD exhibited significantly higher endogenous thrombin potential (ETP) and peak thrombin generation compared to inactive disease and controls.
  • A significant positive correlation was observed between PCDAI scores and thrombin generation parameters.
  • Elevated thrombin generation during active CD is primarily driven by the inflammatory process.

Conclusions:

  • Active Crohn's disease in children is characterized by a heightened potential for thrombin generation.
  • This hypercoagulable state appears to be a consequence of the inflammatory process in CD.
  • Findings suggest inflammation, rather than a pre-existing prothrombotic tendency, drives increased clotting risk in pediatric CD.
Abstract

More Related Videos

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay13:08

Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay

Published on: September 9, 2012

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.